Deferred Tax Assets, Valuation Allowance of PAVmed Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PAVmed Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • PAVmed Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $42,023,000, a 55% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PAVmed Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $42,023,000 -$51,593,000 -55% 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q4 2023 $93,616,000 +$36,112,000 +63% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q4 2022 $57,504,000 +$13,141,000 +30% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q4 2021 $44,363,000 +$18,937,000 +74% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q4 2020 $25,426,000 +$8,718,000 +52% 31 Dec 2020 10-K 06 Apr 2022 2021 FY
Q4 2019 $16,708,000 +$8,150,719 +95% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q4 2018 $8,557,281 +$4,816,640 +129% 31 Dec 2018 10-K 14 Apr 2020 2019 FY
Q4 2017 $3,740,641 +$6,904,666 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q4 2016 $3,164,025 31 Dec 2016 10-K 14 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.